ensifentrine   Click here for help

GtoPdb Ligand ID: 11865

Synonyms: RPL554
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Ensifentrine (RPL-554) is an inhibitor of phosphodiesterases 3 and 4 (PDE3 and PDE4) [2]. It has bronchodilatory action [4,6] that is associated with short-term improvement in lung function [3], and has been investigated for therapeutic potential in asthma and chronic obstructive pulmonary disease (COPD). Ensifentrine also has anti-inflammatory effects in vitro (e.g. reducing TNFα release from human monocytes) and in vivo. Anti-inflammatory action in bronchial epithelial cells from cystic fibrosis patients is likely mediated via inhibition of PDE4 isozymes [5]. Ensifentrine is active when delivered orally or by inhalation [1].

COVID-19: A pilot study of ensifentrine in hospitalised COVID-19 patients was initiated in mid-late 2020.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 112.87
Molecular weight 477.24
XLogP 3.7
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1cc2c(cc1OC)CCn1c2cc(=Nc2c(C)cc(cc2C)C)n(c1=O)CCNC(=O)N
Isomeric SMILES Cc1cc(c(c(c1)C)N=c1cc2c3cc(c(cc3CCn2c(=O)n1CCNC(=O)N)OC)OC)C
InChI InChI=1S/C26H31N5O4/c1-15-10-16(2)24(17(3)11-15)29-23-14-20-19-13-22(35-5)21(34-4)12-18(19)6-8-30(20)26(33)31(23)9-7-28-25(27)32/h10-14H,6-9H2,1-5H3,(H3,27,28,32)
InChI Key CSOBIBXVIYAXFM-UHFFFAOYSA-N